The Emmy-winner is returning to the finance drama after his abrupt exit in season 5.
The move marks a reversal for the actor, who exited his position as the show’s co-lead, playing hedge fund billionaire Bobby Axelrod, after season five. Lewis will appear in six of the new season’s 12 episodes.
Lewis’ departure was explained by his character going on the run from legal troubles. Co-star Corey Stoll was then upped to series regular and his character took over Axe’s company.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Damian Lewis Will Return to ‘Billions’ for Half of Season 7Axe is back. Damian Lewis, who departed Showtime’s “Billions” at the end of Season 5, will return to the series in time for Season 7, the network announced late Monday. Lewis, who…
Weiterlesen »
Trail Blazers star Damian Lillard scores 71 pts — then gets drug testedTrail Blazers star Damian Lillard scored 71 pts — tied for the most in the NBA this season — on Sunday night. Then he had to get drug tested.
Weiterlesen »
Blazers' Damian Lillard Drug Tested After 71-Point GamePortland Trail Blazers star guard Damian Lillard erupted for a career-best 71 points in the team's 131-114 victory over the Houston Rockets on Sunday night, then was summoned to complete a drug test after the game.
Weiterlesen »
Damian Lillard's legacy in Portland is bigger than a ringDon't get it twisted, Lillard wants to win a championship. But for the Trail Blazers star, there's more to basketball -- and life -- than jewelry.
Weiterlesen »
Trail Blazers 131, Rockets 114: Damian Lillard hangs 71 points on Houston in dominant performanceDamian Lillard set dual Trail Blazers franchise records with 13 3-pointers and his 71...
Weiterlesen »
Damian Lillard got drug tested after his 71-point performanceLillard tied Cleveland’s Donovan Mitchell for the most points in a game this season after Mitchell also scored 71 in a win over Chicago on Jan. 2.
Weiterlesen »